6
Participants
Start Date
February 28, 2014
Primary Completion Date
August 14, 2022
Study Completion Date
August 14, 2022
N-acetyl cysteine
Upon completion of baseline (abstinence) 1H-MRS scanning, CU and HC subjects will participate in two additional 1H-MRS scans, including after 2 weeks of placebo and 2 weeks of NAC administration (3600 mg/day) given in double-blind, randomized, counterbalanced order.
[18F]FDG PET scan
All subjects will undergo \[18F\]FDG PET to establish previously demonstrated reductions in glucose utilization in PFC and assess VS/nucleus accumbent metabolism at baseline.
1H MRS
All subjects will undergo three magnetic resonance spectroscopy (1H-MRS) scans at 7T, including before and after two-weeks of placebo and NAC administration.
[11C]APP311 PET scan
All subjects will undergo \[11C\]APP311 PET imaging to investigate whether there are differences in synaptic integrity / neuronal plasticity in the brains of individuals abstinent from cocaine compared to healthy controls at baseline.
Connecticut Mental Health Center, New Haven
National Institute on Drug Abuse (NIDA)
NIH
Yale University
OTHER